首页 > 最新文献

Pancreas最新文献

英文 中文
Poor Performance Status, Diabetes Mellitus, and Statin use are Risk Factors for Decreased Skeletal Muscle Mass During Nab-paclitaxel Plus Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer. 运动状态不佳、糖尿病和他汀类药物的使用是晚期胰腺癌患者在nab -紫杉醇加吉西他滨治疗期间骨骼肌质量下降的危险因素。
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-08 DOI: 10.1097/MPA.0000000000002565
Kiyotsugu Iede, Terumasa Yamada, Hirotoshi Takayama, Shinsuke Nakashima, Ken Nakata, Shusei Tominaga
{"title":"Poor Performance Status, Diabetes Mellitus, and Statin use are Risk Factors for Decreased Skeletal Muscle Mass During Nab-paclitaxel Plus Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer.","authors":"Kiyotsugu Iede, Terumasa Yamada, Hirotoshi Takayama, Shinsuke Nakashima, Ken Nakata, Shusei Tominaga","doi":"10.1097/MPA.0000000000002565","DOIUrl":"https://doi.org/10.1097/MPA.0000000000002565","url":null,"abstract":"","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145006414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuclear Symmetric Dimethylarginine Staining is Indicative of Pancreatic Ductal Adenocarcinoma. 核对称二甲基精氨酸染色提示胰腺导管腺癌。
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-03 DOI: 10.1097/MPA.0000000000002509
Kritisha Bhandari, Sheeja Aravindan, Chao Xu, Kar-Ming Fung, Wei-Qun Ding

Objective: The protein arginine methyltransferase 5 (PRMT5) is a type II PRMT that is responsible for the majority of symmetric dimethylarginine (SDMA) in eukaryotic cells. While PRMT5 is overexpressed in pancreatic ductal adenocarcinoma (PDAC), the SDMA expression patterns in PDAC tissues have not been examined. This study is aimed to characterize the SDMA expression patterns in PDAC cells and patient tissues.

Methods: Tissue microarray (TMA), immunohistochemistry (IHC) of PDAC cell lines and archival PDAC tissue blocks, and western blotting were applied to this study.

Results: Expression of PRMT5 and SDMA is elevated in PANC-1 and MIA PaCa-2 cells compared with that in the pancreatic ductal HPNE cell line. Pharmacological inhibition of PRMT5 reduces the SDMA level, indicating that PRMT5 is primarily responsible for SDMA in PDAC cells. IHC staining of the TMA containing 158 patient samples demonstrates that nuclear SDMA staining is significantly enhanced in PDAC tissues compared to normal and tumor adjacent tissues. The elevated SDMA level is evident in tissues from patients with early-stage PDAC, which is further verified using the archival PDAC tissue blocks. In addition, the SDMA staining is highly clustered in the Islets of Langerhans of the pancreas, irrespective of the disease states.

Conclusions: We demonstrate for the first time that nuclear SDMA staining is significantly enhanced in PDAC tissues and in the Islets of Langerhans of the pancreas, indicating novel tissue IHC markers for PDAC and the endocrine units of the pancreas.

目的:蛋白精氨酸甲基转移酶5 (PRMT5)是一种II型PRMT,负责真核细胞中大部分对称二甲基精氨酸(SDMA)的产生。虽然PRMT5在胰腺导管腺癌(PDAC)中过表达,但SDMA在PDAC组织中的表达模式尚未被研究。本研究旨在表征SDMA在PDAC细胞和患者组织中的表达模式。方法:采用组织芯片(TMA)、PDAC细胞株免疫组化(IHC)、PDAC档案组织块免疫印迹(western blotting)技术进行研究。结果:PANC-1和MIA PaCa-2细胞中PRMT5和SDMA的表达高于胰腺导管HPNE细胞系。药物抑制PRMT5可降低SDMA水平,表明PRMT5在PDAC细胞中主要负责SDMA。158例患者TMA的免疫组化染色显示,与正常组织和肿瘤邻近组织相比,PDAC组织的核SDMA染色明显增强。在早期PDAC患者的组织中,SDMA水平明显升高,这一点通过档案PDAC组织块得到进一步证实。此外,无论疾病状态如何,SDMA染色高度聚集在胰腺的朗格汉斯岛。结论:我们首次证明核SDMA染色在PDAC组织和胰腺朗格汉斯胰岛中显著增强,表明PDAC和胰腺内分泌单位的新组织IHC标记。
{"title":"Nuclear Symmetric Dimethylarginine Staining is Indicative of Pancreatic Ductal Adenocarcinoma.","authors":"Kritisha Bhandari, Sheeja Aravindan, Chao Xu, Kar-Ming Fung, Wei-Qun Ding","doi":"10.1097/MPA.0000000000002509","DOIUrl":"https://doi.org/10.1097/MPA.0000000000002509","url":null,"abstract":"<p><strong>Objective: </strong>The protein arginine methyltransferase 5 (PRMT5) is a type II PRMT that is responsible for the majority of symmetric dimethylarginine (SDMA) in eukaryotic cells. While PRMT5 is overexpressed in pancreatic ductal adenocarcinoma (PDAC), the SDMA expression patterns in PDAC tissues have not been examined. This study is aimed to characterize the SDMA expression patterns in PDAC cells and patient tissues.</p><p><strong>Methods: </strong>Tissue microarray (TMA), immunohistochemistry (IHC) of PDAC cell lines and archival PDAC tissue blocks, and western blotting were applied to this study.</p><p><strong>Results: </strong>Expression of PRMT5 and SDMA is elevated in PANC-1 and MIA PaCa-2 cells compared with that in the pancreatic ductal HPNE cell line. Pharmacological inhibition of PRMT5 reduces the SDMA level, indicating that PRMT5 is primarily responsible for SDMA in PDAC cells. IHC staining of the TMA containing 158 patient samples demonstrates that nuclear SDMA staining is significantly enhanced in PDAC tissues compared to normal and tumor adjacent tissues. The elevated SDMA level is evident in tissues from patients with early-stage PDAC, which is further verified using the archival PDAC tissue blocks. In addition, the SDMA staining is highly clustered in the Islets of Langerhans of the pancreas, irrespective of the disease states.</p><p><strong>Conclusions: </strong>We demonstrate for the first time that nuclear SDMA staining is significantly enhanced in PDAC tissues and in the Islets of Langerhans of the pancreas, indicating novel tissue IHC markers for PDAC and the endocrine units of the pancreas.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144964052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of Additional Hydration for Hyperamylasemia After Endoscopic Retrograde Cholangiopancreatography: A Propensity-matched Analysis. 内镜逆行胆管造影后额外水合治疗高淀酵酶血症的有效性:倾向匹配分析。
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-01 DOI: 10.1097/MPA.0000000000002493
Rintaro Fukuda, Ryunosuke Hakuta, Yousuke Nakai, Hiroto Nishio, Go Endo, Kohei Kurihara, Shuichi Tange, Shinya Takaoka, Hiroki Oyama, Kensaku Noguchi, Tatsunori Suzuki, Tatsuya Sato, Kazunaga Ishigaki, Tomotaka Saito, Naminatsu Takahara, Tsuyoshi Hamada, Yukiko Ito, Mitsuhiro Fujishiro

Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is widely utilized to manage pancreatobiliary diseases, but post-ERCP pancreatitis (PEP) is an unsolved issue. Although postprocedural elevation of serum amylase level is useful for early prediction of PEP, effectiveness of early interventions for hyperamylasemia has not been evaluated. Therefore, we conducted this study to elucidate the role of additional hydration in cases with hyperamylasemia after ERCP.

Materials and methods: This retrospective study included patients without a previous history of ERCP who developed hyperamylasemia 3 hours after the index ERCP in 2 centers. Patients were divided into a hydration group (with additional hydration of Lactated Ringer's solution at a rate of 40-80 mL/h) or a control group (without additional hydration). Using propensity score matching, clinical outcomes, including the incidence and severity of PEP, were compared between the matched hydration and control groups.

Results: A total of 399 patients were eligible for the current analysis and 109 patients for each group were selected after propensity score matching. Patient characteristics and endoscopic procedure details were well-balanced between the matched hydration and control groups. The incidences of overall PEP were not different between the 2 groups (42% vs. 45%, P =0.68), but the incidence of moderate or severe PEP was significantly lower in the matched hydration group (8.3% vs.22%, odds ratio 0.32; P =0.006). Hydration-related complication was not observed in both groups.

Conclusions: Additional hydration for patients with hyperamylasemia after ERCP reduced the incidence of moderate or severe PEP without a risk of volume overload.

目的:内镜逆行胰胆管造影(ERCP)被广泛应用于胰胆道疾病的治疗,但ERCP后胰腺炎(PEP)是一个尚未解决的问题。虽然手术后血清淀粉酶水平的升高有助于PEP的早期预测,但早期干预高淀粉酶血症的有效性尚未得到评估。因此,我们进行了这项研究,以阐明额外的水合作用在ERCP后高淀粉酶血症的病例。方法:本回顾性研究纳入了两个中心无ERCP病史的患者,这些患者在ERCP指数出现后3小时出现高淀粉酶血症。患者被分为水合组(以每小时40-80毫升的速度补充乳酸林格氏液)或对照组(不补充水合)。使用倾向评分匹配,临床结果包括PEP的发生率和严重程度在匹配的水合作用组和对照组之间进行比较。结果:共有399例患者符合当前分析条件,经倾向评分匹配后,每组选择109例患者。患者特征和内镜手术细节在匹配的水合组和对照组之间很好地平衡。两组总体PEP发生率无差异(42% vs. 45%, P=0.68),但匹配水合组中重度PEP发生率显著降低(8.3% vs.22%,优势比0.32;P = 0.006)。两组均未见水化相关并发症。结论:ERCP后高淀粉酶血症患者额外补水可降低中度或重度PEP的发生率,且无容量过载风险。
{"title":"The Effectiveness of Additional Hydration for Hyperamylasemia After Endoscopic Retrograde Cholangiopancreatography: A Propensity-matched Analysis.","authors":"Rintaro Fukuda, Ryunosuke Hakuta, Yousuke Nakai, Hiroto Nishio, Go Endo, Kohei Kurihara, Shuichi Tange, Shinya Takaoka, Hiroki Oyama, Kensaku Noguchi, Tatsunori Suzuki, Tatsuya Sato, Kazunaga Ishigaki, Tomotaka Saito, Naminatsu Takahara, Tsuyoshi Hamada, Yukiko Ito, Mitsuhiro Fujishiro","doi":"10.1097/MPA.0000000000002493","DOIUrl":"10.1097/MPA.0000000000002493","url":null,"abstract":"<p><strong>Objectives: </strong>Endoscopic retrograde cholangiopancreatography (ERCP) is widely utilized to manage pancreatobiliary diseases, but post-ERCP pancreatitis (PEP) is an unsolved issue. Although postprocedural elevation of serum amylase level is useful for early prediction of PEP, effectiveness of early interventions for hyperamylasemia has not been evaluated. Therefore, we conducted this study to elucidate the role of additional hydration in cases with hyperamylasemia after ERCP.</p><p><strong>Materials and methods: </strong>This retrospective study included patients without a previous history of ERCP who developed hyperamylasemia 3 hours after the index ERCP in 2 centers. Patients were divided into a hydration group (with additional hydration of Lactated Ringer's solution at a rate of 40-80 mL/h) or a control group (without additional hydration). Using propensity score matching, clinical outcomes, including the incidence and severity of PEP, were compared between the matched hydration and control groups.</p><p><strong>Results: </strong>A total of 399 patients were eligible for the current analysis and 109 patients for each group were selected after propensity score matching. Patient characteristics and endoscopic procedure details were well-balanced between the matched hydration and control groups. The incidences of overall PEP were not different between the 2 groups (42% vs. 45%, P =0.68), but the incidence of moderate or severe PEP was significantly lower in the matched hydration group (8.3% vs.22%, odds ratio 0.32; P =0.006). Hydration-related complication was not observed in both groups.</p><p><strong>Conclusions: </strong>Additional hydration for patients with hyperamylasemia after ERCP reduced the incidence of moderate or severe PEP without a risk of volume overload.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":"e667-e673"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143701118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using Animations to Educate Children and Caregivers on Pediatric Pancreatitis: Assessing the Impact and Utilization of the National Pancreas Foundation's Pediatric Animated Pancreas Patient. 使用动画来教育儿童和护理人员儿童胰腺炎-评估影响和利用国家胰腺基金会的儿童胰腺病人动画。
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-01 DOI: 10.1097/MPA.0000000000002494
Chinenye R Dike, Mark Lowe, Christopher Forsmark, Stephanie Searle, Jane Holt, Maisam Abu-El-Haija

Objectives: The purpose of this study is to evaluate the impact of animated pancreas patient (APP), pediatric-focused online educational modules on patient and caregiver education.

Methods: Retrospective study of collected APP metrics over 6 years. The audience reaches, and geographic location of the APP site were assessed. Further, we collected data on the top 5 viewed expert and patient videos and evaluated the impact of these modules on patient and provider education through viewer surveys.

Results: There were 226,772 visitors to the APP Pediatric modules on the NPF website over 6 years. They viewed the modules 310,068 times for an average of 51,678 views/year. In contrast, adult modules had 1,475,252 views over a 4-year period with an average of 368,813 views/year. Given the incidence of Pediatric and adult CP in 2014 of 1.9/100,000 persons and 24.7/100,000 persons, respectively, the average yearly views per incidence were 27,198 and 14,932 for children and adults, respectively. Eighty-nine percent of viewers of APP modules on pediatric pancreatitis who completed the feedback survey reported they learned new information.

Conclusion: The average yearly view/incidence for Pediatric modules was 1.8 times higher than for adult modules, with the majority reporting that they learned new information. The popularity of the Pediatric modules confirms that online educational content is highly accessible and successful in educating patients and caregivers about Pediatric pancreatitis and confirms the need to continue to utilize these educational modules now and in the future.

目的:评估动画胰腺患者(APP),儿科在线教育模块对患者和护理人员教育的影响。方法:回顾性研究6年来收集的APP指标。对APP网站的受众范围和地理位置进行了评估。此外,我们收集了观看次数最多的5个专家和患者视频的数据,并通过观众调查评估了这些模块对患者和提供者教育的影响。结果:6年间,NPF网站APP儿科模块的访问量为226,772人次。他们观看了这些模块310,068次,平均每年观看51,678次。相比之下,成人模块在4年期间的观看次数为1,475,252次,平均每年观看次数为368,813次。鉴于2014年儿科和成人CP的发病率分别为1.9/10万人和24.7/10万人,儿童和成人的年平均发病率分别为27,198和14,932。在完成反馈调查的儿童胰腺炎APP模块的观众中,89%的人表示他们了解了新的信息。结论:儿童模块的平均年访问量/发病率是成人模块的1.8倍,大多数报告他们学习了新的信息。儿科模块的普及证实了在线教育内容在教育儿童胰腺炎患者和护理人员方面是高度可访问和成功的,并证实了现在和将来继续利用这些教育模块的必要性。
{"title":"Using Animations to Educate Children and Caregivers on Pediatric Pancreatitis: Assessing the Impact and Utilization of the National Pancreas Foundation's Pediatric Animated Pancreas Patient.","authors":"Chinenye R Dike, Mark Lowe, Christopher Forsmark, Stephanie Searle, Jane Holt, Maisam Abu-El-Haija","doi":"10.1097/MPA.0000000000002494","DOIUrl":"10.1097/MPA.0000000000002494","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study is to evaluate the impact of animated pancreas patient (APP), pediatric-focused online educational modules on patient and caregiver education.</p><p><strong>Methods: </strong>Retrospective study of collected APP metrics over 6 years. The audience reaches, and geographic location of the APP site were assessed. Further, we collected data on the top 5 viewed expert and patient videos and evaluated the impact of these modules on patient and provider education through viewer surveys.</p><p><strong>Results: </strong>There were 226,772 visitors to the APP Pediatric modules on the NPF website over 6 years. They viewed the modules 310,068 times for an average of 51,678 views/year. In contrast, adult modules had 1,475,252 views over a 4-year period with an average of 368,813 views/year. Given the incidence of Pediatric and adult CP in 2014 of 1.9/100,000 persons and 24.7/100,000 persons, respectively, the average yearly views per incidence were 27,198 and 14,932 for children and adults, respectively. Eighty-nine percent of viewers of APP modules on pediatric pancreatitis who completed the feedback survey reported they learned new information.</p><p><strong>Conclusion: </strong>The average yearly view/incidence for Pediatric modules was 1.8 times higher than for adult modules, with the majority reporting that they learned new information. The popularity of the Pediatric modules confirms that online educational content is highly accessible and successful in educating patients and caregivers about Pediatric pancreatitis and confirms the need to continue to utilize these educational modules now and in the future.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":"e694-e697"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143764565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coupled Plasma Filtration and Adsorption in Eliminating Inflammatory Mediators and Enhancing Sublingual Microcirculation in Severe Acute Pancreatitis. 耦合血浆过滤和吸附在严重急性胰腺炎中消除炎症介质和增强舌下微循环。
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-01 DOI: 10.1097/MPA.0000000000002486
Hongli Zhou, Chunjian Ma, ShengNian Zhong

Objective: This study aims to assess the effectiveness of coupled plasma filtration and adsorption (CPFA) in patients with SAP through its effect on inflammatory mediators and sublingual circulating blood volume. The hypothesis put to test is that CPFA can achieve a satisfactory reduction in inflammatory mediators and enhance sublingual microcirculation in SAP with a very good clinical outcome.

Methods: A cohort of 112 SAP patients admitted to the ICU of our institution between January 2018 and December 2022 was consecutively recruited. Participants were randomized to the CPFA or the control group (standard treatment) using a random number table for assignment. Posttreatment alterations in inflammatory mediators and sublingual microcirculation were analyzed and compared.

Results: Following treatment, the study group showed significantly reduced levels of IL-1β, TNF-α, and IL-6 versus the control group. In addition, the study group witnessed lower serum and urinary amylase levels and APACHE II and SOFA scores. Parameters related to sublingual microcirculation, including total vessel density (TVDs), small vessel perfusion ratio (PPVs), perfusion small vessel density (PVDs), and microvascular flow index (MFIs), were significantly improved in the study group. Moreover, the study group observed lower rates of systemic inflammatory response syndrome (SIRS) and 30-day mortality versus the control group.

Conclusions: The application of CPFA in SAP patients effectively eliminates inflammatory mediators and enhances microcirculation, leading to improved clinical outcomes and reduced mortality rates.

目的:本研究旨在通过对炎症介质和舌下循环血容量的影响来评估耦合血浆过滤和吸附(CPFA)在SAP患者中的有效性。检验的假设是CPFA可以达到令人满意的炎症介质减少和增强SAP的舌下微循环,具有非常好的临床结果。方法:连续招募2018年1月至2022年12月我院ICU收治的SAP患者112例。参与者被随机分配到CPFA组或对照组(标准治疗),使用随机数字表进行分配。分析和比较治疗后炎症介质和舌下微循环的变化。结果:治疗后,研究组与对照组相比,IL-1β、TNF-α、IL-6水平明显降低。此外,研究组的血清和尿淀粉酶水平以及APACHE II和SOFA评分均较低。研究组舌下微循环相关参数,包括总血管密度(TVDs)、小血管灌注比(PPVs)、灌注小血管密度(PVDs)、微血管流动指数(mfi)均有显著改善。此外,与对照组相比,研究组的全身性炎症反应综合征(SIRS)和30天死亡率更低。结论:在SAP患者中应用CPFA可有效消除炎症介质,增强微循环,改善临床疗效,降低死亡率。
{"title":"Coupled Plasma Filtration and Adsorption in Eliminating Inflammatory Mediators and Enhancing Sublingual Microcirculation in Severe Acute Pancreatitis.","authors":"Hongli Zhou, Chunjian Ma, ShengNian Zhong","doi":"10.1097/MPA.0000000000002486","DOIUrl":"10.1097/MPA.0000000000002486","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to assess the effectiveness of coupled plasma filtration and adsorption (CPFA) in patients with SAP through its effect on inflammatory mediators and sublingual circulating blood volume. The hypothesis put to test is that CPFA can achieve a satisfactory reduction in inflammatory mediators and enhance sublingual microcirculation in SAP with a very good clinical outcome.</p><p><strong>Methods: </strong>A cohort of 112 SAP patients admitted to the ICU of our institution between January 2018 and December 2022 was consecutively recruited. Participants were randomized to the CPFA or the control group (standard treatment) using a random number table for assignment. Posttreatment alterations in inflammatory mediators and sublingual microcirculation were analyzed and compared.</p><p><strong>Results: </strong>Following treatment, the study group showed significantly reduced levels of IL-1β, TNF-α, and IL-6 versus the control group. In addition, the study group witnessed lower serum and urinary amylase levels and APACHE II and SOFA scores. Parameters related to sublingual microcirculation, including total vessel density (TVDs), small vessel perfusion ratio (PPVs), perfusion small vessel density (PVDs), and microvascular flow index (MFIs), were significantly improved in the study group. Moreover, the study group observed lower rates of systemic inflammatory response syndrome (SIRS) and 30-day mortality versus the control group.</p><p><strong>Conclusions: </strong>The application of CPFA in SAP patients effectively eliminates inflammatory mediators and enhances microcirculation, leading to improved clinical outcomes and reduced mortality rates.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":"e645-e650"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12363305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TNFRSF9 Inhibits Pancreatic Cancer Progression by Regulating PAX6-mediated Cell Proliferation, Migration, and Apoptosis. TNFRSF9通过调节pax6介导的细胞增殖、迁移和凋亡抑制胰腺癌进展。
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-01 DOI: 10.1097/MPA.0000000000002497
Xiaorong Liu, Zhaofeng Gao, Minjie Chen, Fei Chen, Xiaoping Li, Lingyu Hu

Objective: This study aimed to explore the function of TNF receptor superfamily member 9 (TNFRSF9) in pancreatic ductal adenocarcinoma (PDA) by investigating its expression levels and functional implications in PDA cells.

Materials and methods: TNFRSF9 expression was evaluated in patients with PDA, and TNFRSF9 levels were manipulated in PDA cells to assess its effects on cell proliferation, migration, and apoptosis. The downstream target gene PAX6 was also examined. In vivo, studies in nude mice were performed to analyze the impact of TNFRSF9 overexpression on tumor growth.

Results: Analysis revealed decreased TNFRSF9 expression in PDA tissues. Ectopic TNFRSF9 expression in PDA cells suppressed cell proliferation and migration and induced apoptosis, while TNFRSF9 knockout showed opposing effects. PAX6 was identified as a downstream target of TNFRSF9. TNFRSF9 overexpression in nude mice led to reduced tumor growth.

Conclusion: The study suggests that TNFRSF9 may hold promise as a therapeutic target in PDA management, given its potential to inhibit tumor growth and modulate cell behavior.

目的:本研究旨在通过研究TNF受体超家族成员9 (TNFRSF9)在胰腺导管腺癌(PDA)细胞中的表达水平及其功能意义,探讨其在PDA细胞中的功能。方法:在PDA患者中检测TNFRSF9的表达,并在PDA细胞中检测TNFRSF9的表达水平,评估其对细胞增殖、迁移和凋亡的影响。下游靶基因PAX6也进行了检测。在体内,裸鼠实验分析了TNFRSF9过表达对肿瘤生长的影响。结果:分析显示PDA组织中TNFRSF9表达降低。在PDA细胞中异位表达TNFRSF9抑制细胞增殖和迁移,诱导细胞凋亡,而敲除TNFRSF9则表现出相反的作用。PAX6被确定为TNFRSF9的下游靶点。裸鼠中TNFRSF9过表达导致肿瘤生长降低。结论:该研究表明,鉴于TNFRSF9抑制肿瘤生长和调节细胞行为的潜力,它可能有望成为PDA治疗的治疗靶点。
{"title":"TNFRSF9 Inhibits Pancreatic Cancer Progression by Regulating PAX6-mediated Cell Proliferation, Migration, and Apoptosis.","authors":"Xiaorong Liu, Zhaofeng Gao, Minjie Chen, Fei Chen, Xiaoping Li, Lingyu Hu","doi":"10.1097/MPA.0000000000002497","DOIUrl":"10.1097/MPA.0000000000002497","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to explore the function of TNF receptor superfamily member 9 (TNFRSF9) in pancreatic ductal adenocarcinoma (PDA) by investigating its expression levels and functional implications in PDA cells.</p><p><strong>Materials and methods: </strong>TNFRSF9 expression was evaluated in patients with PDA, and TNFRSF9 levels were manipulated in PDA cells to assess its effects on cell proliferation, migration, and apoptosis. The downstream target gene PAX6 was also examined. In vivo, studies in nude mice were performed to analyze the impact of TNFRSF9 overexpression on tumor growth.</p><p><strong>Results: </strong>Analysis revealed decreased TNFRSF9 expression in PDA tissues. Ectopic TNFRSF9 expression in PDA cells suppressed cell proliferation and migration and induced apoptosis, while TNFRSF9 knockout showed opposing effects. PAX6 was identified as a downstream target of TNFRSF9. TNFRSF9 overexpression in nude mice led to reduced tumor growth.</p><p><strong>Conclusion: </strong>The study suggests that TNFRSF9 may hold promise as a therapeutic target in PDA management, given its potential to inhibit tumor growth and modulate cell behavior.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":"e705-e718"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143975830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Abdominal Aortic Calcification on Pancreas Graft Survival in Patients Undergoing Simultaneous Pancreas-kidney Transplantation. 腹主动脉钙化对胰肾联合移植患者胰腺移植存活的影响。
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-01 DOI: 10.1097/MPA.0000000000002487
Shohei Takaichi, Yoshito Tomimaru, Shogo Kobayashi, Toshinori Ito, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Takehiro Noda, Hidenori Takahashi, Yuichiro Doki, Hidetoshi Eguchi

Background: Pancreas transplantation (PTx) is a definitive therapy for patients with type 1 diabetes and advanced chronic kidney disease. Abdominal aortic calcification (AAC) is often observed in patients waiting for PTx and progresses according to the waiting period, but the impact of AAC on long-term outcomes remains unclear. In this study, we aimed to elucidate the impact of AAC on long-term outcomes.

Methods: We reviewed 65 consecutive PTx cases at our institution between April 2000 and November 2022 and enrolled 50 patients with simultaneous pancreas-kidney transplantation (SPK). AAC was assessed as AAC score by the Agatston method using multidetector computed tomography.

Results: Receiver operating characteristic curves were used to determine the cutoff value of the AAC score for death-uncensored pancreas graft survival; the area under the curve was 0.711 ( P =0.029). After dividing the patients into 2 groups according to the AAC cutoff, the dialysis period was significantly longer in the high AAC score group than in the low AAC score group ( P =0.001). Death-uncensored pancreas graft survival and patient survival after SPK were significantly lower in the high AAC score group than in the low AAC score group ( P =0.001, 0.001, respectively). In a Cox proportional hazards regression model, a high AAC score was independently associated with death-uncensored pancreas graft loss ( P =0.002).

Conclusions: AAC is associated with death-uncensored pancreas graft survival in patients undergoing SPK. Evaluation of AAC could be useful for predicting post-PTx prognosis.

背景:胰腺移植(PTx)是1型糖尿病和晚期慢性肾脏疾病患者的最终治疗方法。腹主动脉钙化(AAC)常见于等待PTx的患者,并根据等待时间进展,但AAC对长期预后的影响尚不清楚。在本研究中,我们旨在阐明AAC对长期预后的影响。方法:我们回顾了2000年4月至2022年11月在我院连续发生的65例PTx病例,并纳入了50例同步胰肾移植(SPK)患者。AAC采用多检测器计算机断层扫描Agatston法评定为AAC评分。结果:采用受试者工作特征曲线确定死亡-未审查胰腺移植存活的AAC评分临界值;曲线下面积为0.711 (P=0.029)。根据AAC分界点将患者分为两组,AAC评分高组透析时间明显长于AAC评分低组(P=0.001)。高AAC评分组的死亡-未审查胰腺移植生存率和SPK后患者生存率显著低于低AAC评分组(P分别=0.001和0.001)。在Cox比例风险回归模型中,高AAC评分与死亡-未审查胰腺移植损失独立相关(P=0.002)。结论:AAC与SPK患者的死亡-未审查胰腺移植生存相关。评估AAC可用于预测ptx后的预后。
{"title":"Impact of Abdominal Aortic Calcification on Pancreas Graft Survival in Patients Undergoing Simultaneous Pancreas-kidney Transplantation.","authors":"Shohei Takaichi, Yoshito Tomimaru, Shogo Kobayashi, Toshinori Ito, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Takehiro Noda, Hidenori Takahashi, Yuichiro Doki, Hidetoshi Eguchi","doi":"10.1097/MPA.0000000000002487","DOIUrl":"10.1097/MPA.0000000000002487","url":null,"abstract":"<p><strong>Background: </strong>Pancreas transplantation (PTx) is a definitive therapy for patients with type 1 diabetes and advanced chronic kidney disease. Abdominal aortic calcification (AAC) is often observed in patients waiting for PTx and progresses according to the waiting period, but the impact of AAC on long-term outcomes remains unclear. In this study, we aimed to elucidate the impact of AAC on long-term outcomes.</p><p><strong>Methods: </strong>We reviewed 65 consecutive PTx cases at our institution between April 2000 and November 2022 and enrolled 50 patients with simultaneous pancreas-kidney transplantation (SPK). AAC was assessed as AAC score by the Agatston method using multidetector computed tomography.</p><p><strong>Results: </strong>Receiver operating characteristic curves were used to determine the cutoff value of the AAC score for death-uncensored pancreas graft survival; the area under the curve was 0.711 ( P =0.029). After dividing the patients into 2 groups according to the AAC cutoff, the dialysis period was significantly longer in the high AAC score group than in the low AAC score group ( P =0.001). Death-uncensored pancreas graft survival and patient survival after SPK were significantly lower in the high AAC score group than in the low AAC score group ( P =0.001, 0.001, respectively). In a Cox proportional hazards regression model, a high AAC score was independently associated with death-uncensored pancreas graft loss ( P =0.002).</p><p><strong>Conclusions: </strong>AAC is associated with death-uncensored pancreas graft survival in patients undergoing SPK. Evaluation of AAC could be useful for predicting post-PTx prognosis.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":"e651-e660"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143649805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum 25-Hydroxyvitamin D and Vitamin D Receptor Genetic Polymorphisms are Associated With Prognosis of Acute Pancreatitis. 血清25-羟基维生素D和维生素D受体遗传多态性与急性胰腺炎预后相关
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-01 DOI: 10.1097/MPA.0000000000002496
Yu Liu, Yangxi Chen, Lei Guo, Chen Yang, Haiyang Jiang, Xiang Yang, Zhihui Tong, Xinghu Zhang, Fang Huang, Lei Lv, Wenhui Wan

Objectives: This study investigated the relationship between serum 25-Hydroxyvitamin D [25(OH)D] levels, vitamin D receptor (VDR) gene polymorphisms, and the prognosis of acute pancreatitis (AP).

Methods: This prospective observation study included patients with AP admitted to the Jinling Hospital between January 2018 and December 2019. Clinical information, laboratory tests, and single-nucleotide polymorphisms (SNPs) of the VDR gene were collected.

Results: A total of 508 AP patients were included, with a mean age of 44.81 ± 13.80 years. Among them, 158 (31.10%) cases developed sepsis, 211 (41.54%) cases had serious AP, and 47 (9.25%) patients died before discharge. The multivariate regression analysis showed that VD deficiency was an independent risk factor for the occurrence of sepsis (OR=3.768, 95% CI: 2.368-5.997, P <0.001), progression of AP patients to serious AP (OR=4.297, 95% CI: 2.806-6.582, P <0.001), and in-hospital mortality in AP patients (OR=2.406, 95% CI: 1.162-4.984, P =0.018). SNPs of VDR associated with sepsis, serious AP, or in-hospital death were identified, including rs12721375, rs2853559, rs11168287, rs2853559, and rs11168283 (all P <0.05). The Generalized Multifactor Dimensionality Reduction model analysis revealed that a 4-order model (rs11168283, rs11168287, rs2853559, and 25(OH)D) was the best model for predicting death ( P <0.01).

Conclusions: VD deficiency and VDR genetic polymorphisms are associated with AP prognosis in Chinese Han patients with AP. VDR genetic polymorphism may influence the outcomes of AP patients by affecting the levels of inflammatory cytokines.

目的:探讨血清25-羟基维生素D [25(OH)D]水平、维生素D受体(VDR)基因多态性与急性胰腺炎(AP)预后的关系。方法:本前瞻性观察研究纳入2018年1月至2019年12月在金陵医院住院的AP患者。收集临床资料、实验室检测结果和VDR基因的单核苷酸多态性(snp)。结果:共纳入508例AP患者,平均年龄44.81±13.80岁。其中败血症158例(31.10%),严重AP 211例(41.54%),出院前死亡47例(9.25%)。多因素回归分析显示VD缺乏是脓毒症发生的独立危险因素(OR=3.768, 95% CI: 2.368 ~ 5.997)。结论:VD缺乏和VDR基因多态性与中国汉族AP患者AP预后相关,VDR基因多态性可能通过影响炎症细胞因子水平影响AP患者预后。
{"title":"Serum 25-Hydroxyvitamin D and Vitamin D Receptor Genetic Polymorphisms are Associated With Prognosis of Acute Pancreatitis.","authors":"Yu Liu, Yangxi Chen, Lei Guo, Chen Yang, Haiyang Jiang, Xiang Yang, Zhihui Tong, Xinghu Zhang, Fang Huang, Lei Lv, Wenhui Wan","doi":"10.1097/MPA.0000000000002496","DOIUrl":"10.1097/MPA.0000000000002496","url":null,"abstract":"<p><strong>Objectives: </strong>This study investigated the relationship between serum 25-Hydroxyvitamin D [25(OH)D] levels, vitamin D receptor (VDR) gene polymorphisms, and the prognosis of acute pancreatitis (AP).</p><p><strong>Methods: </strong>This prospective observation study included patients with AP admitted to the Jinling Hospital between January 2018 and December 2019. Clinical information, laboratory tests, and single-nucleotide polymorphisms (SNPs) of the VDR gene were collected.</p><p><strong>Results: </strong>A total of 508 AP patients were included, with a mean age of 44.81 ± 13.80 years. Among them, 158 (31.10%) cases developed sepsis, 211 (41.54%) cases had serious AP, and 47 (9.25%) patients died before discharge. The multivariate regression analysis showed that VD deficiency was an independent risk factor for the occurrence of sepsis (OR=3.768, 95% CI: 2.368-5.997, P <0.001), progression of AP patients to serious AP (OR=4.297, 95% CI: 2.806-6.582, P <0.001), and in-hospital mortality in AP patients (OR=2.406, 95% CI: 1.162-4.984, P =0.018). SNPs of VDR associated with sepsis, serious AP, or in-hospital death were identified, including rs12721375, rs2853559, rs11168287, rs2853559, and rs11168283 (all P <0.05). The Generalized Multifactor Dimensionality Reduction model analysis revealed that a 4-order model (rs11168283, rs11168287, rs2853559, and 25(OH)D) was the best model for predicting death ( P <0.01).</p><p><strong>Conclusions: </strong>VD deficiency and VDR genetic polymorphisms are associated with AP prognosis in Chinese Han patients with AP. VDR genetic polymorphism may influence the outcomes of AP patients by affecting the levels of inflammatory cytokines.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":"e698-e704"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
N-acetyltransferase 10 Promotes Pancreatic Cancer Progression Through ZEB1/MT1-MMP Axis. n -乙酰转移酶10通过ZEB1/MT1-MMP轴促进胰腺癌进展
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-01 DOI: 10.1097/MPA.0000000000002492
Fangxia Wang, Yumeng Hu, Shaobo Zhang, Yuxin Ye, Haoran Qi, Yan Xu, Hui Zhang, Mingyang Liu

Objectives: To elucidate the role of N-acetyltransferase 10 (NAT10) in pancreatic cancer (PC) progression and its epigenetic mechanisms, particularly in relation to metastasis.

Methods: TCGA and GTEx databases were used to analyze the expression and roles of NAT10 in pancreatic cancer. We constructed stable cell lines with NAT10 knockdown in PC cell lines, AsPC-1 and KPC. CCK-8, EdU assay, and colony formation assay were conducted to evaluate the capability of cell proliferation and clonogenesis in vitro. Meanwhile, a transwell assay was performed to assess the impact on invasion and metastasis abilities. The correlation between NAT10 and ZEB1 expression was verified by correlation analysis. The underlying mechanisms through which NAT10 regulates ZEB1 were confirmed by qPCR, western blot, RIP-qPCR, dot plot, and mRNA stability assay. Furthermore, the interplay among NAT10, ZEB1, and MT1-MMP was confirmed using similar experimental approaches. Rescue experiments involving ZEB1 overexpression further verified the role of NAT10/ZEB1/MT1-MMP axis in PC metastasis. In addition, the NAT10 inhibitor Remodelin was employed in a nude orthotopic PC model to investigate its effects on metastasis in vivo.

Results: NAT10 was found to be upregulated in PC and was significantly associated with poor prognosis. After NAT10 knockdown, the ability of proliferation and metastasis of AsPC-1 and KPC was remarkably impaired, the degree of ac4C modification was decreased, and the mRNA stability of ZEB1 declined. Correlation analysis indicated a positive correlation among NAT10, ZEB1, and MT1-MMP, and the results of qPCR and western blot also verified this conclusion. Moreover, ZEB1 overexpression could significantly reverse the inhibition of migration and invasion induced by NAT10 depletion in AsPC-1. NAT10 inhibitor Remodelin treatment could reduce the degree of peritoneal and liver metastases in vivo.

Conclusions: Our study highlights the pivotal functions of NAT10 in the progression of PC and reveals the underlying epigenetic mechanism that NAT10 promotes metastasis via ZEB1/MT1-MMP axis.

目的:阐明n -乙酰转移酶10 (NAT10)在胰腺癌(PC)进展中的作用及其表观遗传机制,特别是与转移有关。方法:采用TCGA和GTEx数据库分析NAT10在胰腺癌中的表达及其作用。我们在PC细胞株、AsPC-1细胞株和KPC细胞株中构建了NAT10敲低的稳定细胞株。采用CCK-8法、EdU法和集落形成法评价细胞体外增殖和克隆发生能力。同时,进行transwell实验来评估对侵袭和转移能力的影响。通过相关分析验证NAT10与ZEB1表达的相关性。通过qPCR、western blot、RIP-qPCR、点阵图和mRNA稳定性实验证实了NAT10调控ZEB1的潜在机制。此外,使用类似的实验方法证实了NAT10、ZEB1和MT1-MMP之间的相互作用。涉及ZEB1过表达的拯救实验进一步验证了NAT10/ZEB1/MT1-MMP轴在PC转移中的作用。此外,我们将NAT10抑制剂重塑素应用于裸体原位PC模型,研究其对体内转移的影响。结果:NAT10在PC中表达上调,与预后不良显著相关。NAT10敲低后,AsPC-1和KPC的增殖转移能力明显受损,ac4C修饰程度降低,ZEB1 mRNA稳定性下降。相关分析表明NAT10、ZEB1和MT1-MMP呈正相关,qPCR和western blot结果也证实了这一结论。此外,ZEB1过表达可以显著逆转NAT10缺失对AsPC-1迁移和侵袭的抑制作用。体内治疗NAT10抑制剂重塑蛋白可降低腹膜和肝脏转移程度。结论:我们的研究突出了NAT10在PC进展中的关键作用,揭示了NAT10通过ZEB1/MT1-MMP轴促进转移的潜在表观遗传机制。
{"title":"N-acetyltransferase 10 Promotes Pancreatic Cancer Progression Through ZEB1/MT1-MMP Axis.","authors":"Fangxia Wang, Yumeng Hu, Shaobo Zhang, Yuxin Ye, Haoran Qi, Yan Xu, Hui Zhang, Mingyang Liu","doi":"10.1097/MPA.0000000000002492","DOIUrl":"10.1097/MPA.0000000000002492","url":null,"abstract":"<p><strong>Objectives: </strong>To elucidate the role of N-acetyltransferase 10 (NAT10) in pancreatic cancer (PC) progression and its epigenetic mechanisms, particularly in relation to metastasis.</p><p><strong>Methods: </strong>TCGA and GTEx databases were used to analyze the expression and roles of NAT10 in pancreatic cancer. We constructed stable cell lines with NAT10 knockdown in PC cell lines, AsPC-1 and KPC. CCK-8, EdU assay, and colony formation assay were conducted to evaluate the capability of cell proliferation and clonogenesis in vitro. Meanwhile, a transwell assay was performed to assess the impact on invasion and metastasis abilities. The correlation between NAT10 and ZEB1 expression was verified by correlation analysis. The underlying mechanisms through which NAT10 regulates ZEB1 were confirmed by qPCR, western blot, RIP-qPCR, dot plot, and mRNA stability assay. Furthermore, the interplay among NAT10, ZEB1, and MT1-MMP was confirmed using similar experimental approaches. Rescue experiments involving ZEB1 overexpression further verified the role of NAT10/ZEB1/MT1-MMP axis in PC metastasis. In addition, the NAT10 inhibitor Remodelin was employed in a nude orthotopic PC model to investigate its effects on metastasis in vivo.</p><p><strong>Results: </strong>NAT10 was found to be upregulated in PC and was significantly associated with poor prognosis. After NAT10 knockdown, the ability of proliferation and metastasis of AsPC-1 and KPC was remarkably impaired, the degree of ac4C modification was decreased, and the mRNA stability of ZEB1 declined. Correlation analysis indicated a positive correlation among NAT10, ZEB1, and MT1-MMP, and the results of qPCR and western blot also verified this conclusion. Moreover, ZEB1 overexpression could significantly reverse the inhibition of migration and invasion induced by NAT10 depletion in AsPC-1. NAT10 inhibitor Remodelin treatment could reduce the degree of peritoneal and liver metastases in vivo.</p><p><strong>Conclusions: </strong>Our study highlights the pivotal functions of NAT10 in the progression of PC and reveals the underlying epigenetic mechanism that NAT10 promotes metastasis via ZEB1/MT1-MMP axis.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":"54 8","pages":"e674-e683"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144883396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic and Surgical Treatments for Painful Chronic Pancreatitis: A Scoping Review of Pain Assessment Tools and Meta-analysis of Outcomes. 疼痛性慢性胰腺炎的内镜和手术治疗:疼痛评估工具的范围回顾和结果的荟萃分析。
IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-01 DOI: 10.1097/MPA.0000000000002495
Mahya Faghih, Mitchell L Ramsey, Misbah Unnisa, Anna E Phillips, Katie Lobner, Samuel Han, Phil A Hart, Elham Afghani, Benjamin L Bick, Dhiraj Yadav, John A Windsor, Søren S Olesen, Vikesh K Singh, Asbjørn M Drewes

Objective: Managing painful chronic pancreatitis (CP) often involves invasive treatments, but success rates are variable. We aimed to describe the pain assessment tools used to measure the efficacy of endotherapy and surgery for painful CP and perform a meta-analysis of outcomes.

Design: PubMed, Embase, and Scopus databases were searched for published studies through April 1, 2023. Full papers in English that assessed pain outcomes among adults with painful CP undergoing invasive interventions were included.

Results: There were 413 out of 1,282 studies that underwent full-text review, and 279 studies were selected for the scoping review. Most commonly used pain assessment tools included symptom description (n=68 studies), numeric pain rating scales (NRS) or visual analog scales (VAS) (n=52), binary pain relief (yes or no) (n=27), and the pancreatitis-specific 4-item Izbicki score (n=28). In a meta-analysis of studies reporting preintervention and postintervention NRS or VAS (0-100), the mean decrease in pain after endoscopic intervention (n=9 studies) was 40.3 (95% CI: 27-53.6, P <0.001) and after surgical intervention (n=12 studies) it was 43.2 (95% CI: 31.5-54.9, P <0.001). A separate meta-analysis of studies reporting the preintervention and postintervention Izbicki score (n=5) showed similar findings. There was no difference in the change in pain scores between endotherapy and surgical cohorts in studies using NRS/VAS or Izbicki scores.

Conclusions: Pain outcomes were similar between endotherapy and surgery for painful CP based on the use of simple and highly variable pain assessment tools. Referral bias and sham effects need to be considered in future trials.

目的:治疗疼痛性慢性胰腺炎(CP)通常涉及侵入性治疗,但成功率不一。我们的目的是描述用于测量疼痛性CP的内镜治疗和手术疗效的疼痛评估工具,并对结果进行荟萃分析。设计:检索PubMed、Embase和Scopus数据库,检索截至2023年4月1日已发表的研究。评估成人疼痛性CP患者接受侵入性干预的疼痛结果的英文全文被收录。结果:1282项研究中有413项进行了全文综述,279项研究被纳入范围综述。最常用的疼痛评估工具包括症状描述(n=68项研究)、数字疼痛评定量表(NRS)或视觉模拟量表(VAS) (n=52)、二元疼痛缓解(是或否)(n=27)和胰腺炎特异性4项Izbicki评分(n=28)。在一项荟萃分析中,研究报告了干预前和干预后的NRS或VAS(0-100),内镜干预后疼痛的平均减少(n=9项研究)为40.3(95%可信区间[CI], 27-53.6)。结论:基于使用简单和高度可变的疼痛评估工具,疼痛性CP的内镜治疗和手术之间的疼痛结局相似。在未来的试验中需要考虑转诊偏倚和假效应。
{"title":"Endoscopic and Surgical Treatments for Painful Chronic Pancreatitis: A Scoping Review of Pain Assessment Tools and Meta-analysis of Outcomes.","authors":"Mahya Faghih, Mitchell L Ramsey, Misbah Unnisa, Anna E Phillips, Katie Lobner, Samuel Han, Phil A Hart, Elham Afghani, Benjamin L Bick, Dhiraj Yadav, John A Windsor, Søren S Olesen, Vikesh K Singh, Asbjørn M Drewes","doi":"10.1097/MPA.0000000000002495","DOIUrl":"10.1097/MPA.0000000000002495","url":null,"abstract":"<p><strong>Objective: </strong>Managing painful chronic pancreatitis (CP) often involves invasive treatments, but success rates are variable. We aimed to describe the pain assessment tools used to measure the efficacy of endotherapy and surgery for painful CP and perform a meta-analysis of outcomes.</p><p><strong>Design: </strong>PubMed, Embase, and Scopus databases were searched for published studies through April 1, 2023. Full papers in English that assessed pain outcomes among adults with painful CP undergoing invasive interventions were included.</p><p><strong>Results: </strong>There were 413 out of 1,282 studies that underwent full-text review, and 279 studies were selected for the scoping review. Most commonly used pain assessment tools included symptom description (n=68 studies), numeric pain rating scales (NRS) or visual analog scales (VAS) (n=52), binary pain relief (yes or no) (n=27), and the pancreatitis-specific 4-item Izbicki score (n=28). In a meta-analysis of studies reporting preintervention and postintervention NRS or VAS (0-100), the mean decrease in pain after endoscopic intervention (n=9 studies) was 40.3 (95% CI: 27-53.6, P <0.001) and after surgical intervention (n=12 studies) it was 43.2 (95% CI: 31.5-54.9, P <0.001). A separate meta-analysis of studies reporting the preintervention and postintervention Izbicki score (n=5) showed similar findings. There was no difference in the change in pain scores between endotherapy and surgical cohorts in studies using NRS/VAS or Izbicki scores.</p><p><strong>Conclusions: </strong>Pain outcomes were similar between endotherapy and surgery for painful CP based on the use of simple and highly variable pain assessment tools. Referral bias and sham effects need to be considered in future trials.</p>","PeriodicalId":19733,"journal":{"name":"Pancreas","volume":" ","pages":"e684-e693"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144064325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pancreas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1